Related Experiment Videos
Does the renin-angiotensin-aldosterone system modify cardiac structure and function in essential hypertension?
R E Schmieder1, F H Messerli, G E Garavaglia
1Ochsner Clinic, New Orleans, Louisiana 70121.
The American Journal of Medicine
|March 11, 1988
Summary
Angiotensin II significantly impacts left ventricular structure in essential hypertension patients. While plasma renin activity influences function, angiotensin II is key to structural changes, highlighting its role in hypertension adaptation.
Area of Science:
- Cardiology
- Endocrinology
- Hypertension Research
Background:
- The renin-angiotensin-aldosterone system (RAAS) plays a crucial role in cardiovascular regulation.
- Essential hypertension is associated with alterations in left ventricular structure and function.
Purpose of the Study:
- To investigate the specific impact of RAAS components on left ventricular (LV) function and structure in untreated essential hypertension.
- To identify which RAAS endocrine parameters are associated with LV adaptations.
Main Methods:
- M-mode echocardiography to assess LV structure (posterior wall thickness, relative wall thickness, LV mass).
- Radioimmunoassay to measure plasma renin activity, aldosterone, angiotensin I, and angiotensin II levels.
- Statistical analysis including correlation and stepwise multiple regression.
Main Results:
- Angiotensin II levels significantly correlated with posterior wall thickness and relative wall thickness.
- Plasma renin activity, but not angiotensin II, positively correlated with ejection fraction and velocity of circumferential fiber shortening.
- Angiotensin II's association with LV structure was confirmed independently of arterial pressure, obesity, and sodium excretion.
Conclusions:
- Angiotensin II is a significant determinant of left ventricular structural adaptation in essential hypertension.
- RAAS components differentially affect LV structure and function in hypertensive patients.
- These findings underscore the importance of targeting the RAAS in managing hypertensive heart disease.